Paramethoxyamphetamine (PMA) poisoning; a ‘party drug’ with lethal effects

  title={Paramethoxyamphetamine (PMA) poisoning; a ‘party drug’ with lethal effects},
  author={S. Refstad},
  journal={Acta Anaesthesiologica Scandinavica},
  • S. Refstad
  • Published 2003
  • Medicine
  • Acta Anaesthesiologica Scandinavica
Among young people in Norway the recreational use of amphetamine derivatives seems to be increasing. Methylenedioxymethamphetamine (MDMA), known as ecstasy, is the dominant substance, having both stimulant and psychedelic properties. Depending on the illegal source of these so‐called ‘party drugs’ the content and purity can vary. This case report describes the first lethal case of paramethoxyamphetamine (PMA) and paramethoxymethamphetamine (PMMA) intoxication reported in Norway. 
Rhabdomyolysis in MDMA intoxication: a rapid and underestimated killer. "Clean" Ecstasy, a safe party drug?
There is still a need to educate the public about the dangers of this so-called "safe" party drug, and to increase the awareness of potential mortality in MDMA use. Expand
Para-methoxymethamphetamine (PMMA): A study of risk factors for fatal intoxication with emphasis on metabolite pattern and CYP genetics
All fatalities attributed to PMMA had high PMMA blood concentrations compared to non-fatal cases, and a public warning is warranted against use and overdose with illegal ‘‘ecstasy’’ or “‘speed”’ drugs. Expand
The antemortem neurobehavior in fatal paramethoxymethamphetamine usage.
Forensic autopsy showed variable findings, ranging from no remarkable change to significant pathological damage similar to serotonin syndrome in both groups of patients, and PMMA seems to enhance serotoninergism than dopaminergism, and exerts a concentration-related dual effect on human. Expand
Overview of Amphetamine-Type Stimulant Mortality Data – UK, 1997–2007
With respect to AMP/METH, ecstasy was here more typically identified in victims who were young, healthy, and less likely to be known as drug users; excess ecstasy-related fatality rates in young users may be a reason for concern. Expand
Teenage toxins: Recreational poisoning in the adolescent
  • N. Gunja
  • Medicine
  • Journal of paediatrics and child health
  • 2012
The clinician needs to be aware of the variety of pharmacologically active substances available in the recreational marketplace in order to diagnose and manage teenagers presenting to hospital with toxidromes. Expand
Comparative potencies of 3,4‐methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5‐HT transport in mammalian cell lines
Illegal ‘ecstasy’ tablets frequently contain 3,4‐methylenedioxymethamphetamine (MDMA)‐like compounds of unknown pharmacological activity, and a number of MDMA analogues have been tested for their ability to inhibit [3H]noradrenaline uptake into rat PC12 cells expressing the noradrenalin transporter (NET). Expand
Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series.
Exposure to PMMA was characterized by multiorgan dysfunction and serotonin syndrome, followed by cardiovascular collapse, and clinicians must anticipate multiple clinical effects from the increased release of dopamine, serotonin, norepinephrine and other neurotransmitters. Expand
Effects of MDMA on body temperature in humans
Mechanistic clinical studies indicate that the MDMA-induced elevations in body temperature in humans partially depend on the ecstasy-induced release of norepinephrine and involve enhanced metabolic heat generation and cutaneous vasoconstriction, resulting in impaired heat dissipation. Expand
Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration.
Study of the disposition and kinetic profile of PMMA and its metabolites in rat plasma and selected tissues after the bolus subcutaneous dose of 40mg/kg could be useful for subsequent evaluation of the psychotropic or neurotoxic effects of PM MA and for diagnostic concern of intoxication. Expand
Synthetic Amphetamine Derivatives
Amphetamine derivatives share a common phenylethylamine chemical skeleton that, with subtle structural modifications, can result in a diverse array of drugs capable of producing varied and discreteExpand


Recent paramethoxyamphetamine deaths.
PMA appeared to be more toxic than MDMA, and blood levels greater than 0.5 mg/L seemed likely to be associated with toxic effects, according to toxicology findings in six fatalities involving the drug. Expand
PMA deaths in Ontario.
  • G. Cimbura
  • Medicine
  • Canadian Medical Association journal
  • 1974
A new street-drug, para-methoxyamphetamine (PMA), recently made its appearance in Ontario and appears to have a powerful hallucinogenic effect as well as a marked toxicity to the central nervous system. Expand
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
The risk of adverse reactions to 3,4-methylenedioxymethamphetamine (MDMA), more commonly known as "ecstasy", is now widely known in both the USA and UK, but the patterns of illness remain varied. WeExpand
Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?
The number of deaths due to amphetamine derivatives apparently due to substitution of PMA for MDMA (Ecstasy) have recently increased markedly in Adelaide, and potential users are warned that PMA has a much higher rate of lethal complications than other designer drugs, and that no guarantee can be made that tablets sold as Ecstasy are not PMA. Expand
Exertional heat stroke induced by amphetamine analogues
It is believed that a controlled trial should be carried out in amphetamine‐related hyperthermia before the use of dantrolene becomes widespread and one of the authors' patients died but the others all survived. Expand
Initial Characterization of PMMA as a Discriminative Stimulus1
The results of these studies suggest that PMMA is an MDMA-like agent that lacks the amphetamine-like stimulant character of MDMA. Expand
Resurgence of a lethal drug: paramethoxyamphetamine deaths in Belgium.